LAVURCHIN® Receives Japanese Pharmaceutical Regulatory Approval as a Radiosensitizer for Dogs
- 15/09/2023
September 15, 2023 – Malignant Tumor Treatment Technologies Inc. announced today that the Japanese pharmaceutical regulatory agency, the Ministry of Agriculture, Forestry, and Fisheries, has granted approval for LAVURCHIN.
※Please refer to the attached file for details.
